Ubp43 gene expression is required for normal Isg15 expression and fetal development

Area of Science:

• Reproductive biology
• Immunology
• Developmental biology

Background:

• Isg15 protein modification is essential during early pregnancy.
• Ubp43 (Usp18) protease cleaves Isg15 conjugates.
• The Isg15 system's role in later gestation implantation sites was unexamined.

Purpose of the Study:

• To investigate the role of Ubp43 in regulating Isg15 at murine implantation sites.
• To determine the impact of Ubp43 deletion on pregnancy outcomes.

Main Methods:

• Analysis of implantation sites (mesometrial and chorioallantoic placenta) from Ubp43 heterozygous and null mice at 12.5 and 17.5 days post-coitum.
• Quantification of free and conjugated Isg15, Isg15 mRNA, and VEGF protein.
• Assessment of fetal genotype ratios and implantation site vasculature.

Main Results:

• Ubp43 deletion increased free and conjugated Isg15 in the chorioallantoic placenta at 17.5 dpc.
• Ubp43 null fetuses exhibited reduced viability, with altered fetal genotype ratios.
• Null placentas showed disrupted implantation sites, reduced vasculature, and increased Isg15 mRNA and VEGF.

Conclusions:

• Isg15 and its conjugates are present in implantation sites throughout mid to late gestation.
• Ubp43 deletion leads to increased Isg15 at the feto-maternal interface and causes fetal death.
• The Isg15 system, regulated by Ubp43, is critical for successful pregnancy maintenance.